Insider Transactions in Q1 2025 at Cytokinetics Inc (CYTK)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 04
2025
|
Fady Ibraham Malik EVP Research & Development |
SELL
Open market or private sale
|
Direct |
2,000
-1.69%
|
$96,000
$48.06 P/Share
|
|
Feb 04
2025
|
Fady Ibraham Malik EVP Research & Development |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+1.67%
|
$20,000
$10.6 P/Share
|
|
Jan 21
2025
|
Fady Ibraham Malik EVP Research & Development |
SELL
Open market or private sale
|
Direct |
2,000
-1.69%
|
$90,000
$45.92 P/Share
|
|
Jan 21
2025
|
Fady Ibraham Malik EVP Research & Development |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+1.67%
|
$20,000
$10.6 P/Share
|
|
Jan 07
2025
|
Fady Ibraham Malik EVP Research & Development |
SELL
Open market or private sale
|
Direct |
2,000
-1.69%
|
$98,000
$49.32 P/Share
|
|
Jan 07
2025
|
Fady Ibraham Malik EVP Research & Development |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+1.67%
|
$20,000
$10.6 P/Share
|
|
Jan 02
2025
|
Edward M. Md Kaye Director |
BUY
Grant, award, or other acquisition
|
Direct |
255
+0.98%
|
$12,240
$48.93 P/Share
|
|
Jan 02
2025
|
Robert Arthur Harrington Director |
BUY
Grant, award, or other acquisition
|
Direct |
255
+1.57%
|
$12,240
$48.93 P/Share
|
|
Jan 02
2025
|
John T Henderson Director |
BUY
Grant, award, or other acquisition
|
Direct |
434
+0.88%
|
$20,832
$48.93 P/Share
|
|
Jan 02
2025
|
Wendall Wierenga Director |
BUY
Grant, award, or other acquisition
|
Direct |
127
+0.51%
|
$6,096
$48.93 P/Share
|
|
Jan 02
2025
|
Nancy Wysenski Director |
BUY
Grant, award, or other acquisition
|
Direct |
127
+0.55%
|
$6,096
$48.93 P/Share
|